Detalhe da pesquisa
1.
Activation of glycogen synthase kinase-3 beta mediates ß-amyloid induced neuritic damage in Alzheimer's disease.
Neurobiol Dis
; 45(1): 425-37, 2012 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-21945540
2.
Serum insulin-like growth factor I regulates brain amyloid-beta levels.
Nat Med
; 8(12): 1390-7, 2002 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-12415260
3.
Triflusal reduces dense-core plaque load, associated axonal alterations and inflammatory changes, and rescues cognition in a transgenic mouse model of Alzheimer's disease.
Neurobiol Dis
; 38(3): 482-91, 2010 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-20149872
4.
A novel GSK-3beta inhibitor reduces Alzheimer's pathology and rescues neuronal loss in vivo.
Neurobiol Dis
; 35(3): 359-67, 2009 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-19523516
5.
The human DIMINUTO/DWARF1 homolog seladin-1 confers resistance to Alzheimer's disease-associated neurodegeneration and oxidative stress.
J Neurosci
; 20(19): 7345-52, 2000 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-11007892
6.
Current advances on different kinases involved in tau phosphorylation, and implications in Alzheimer's disease and tauopathies.
Curr Alzheimer Res
; 2(1): 3-18, 2005 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-15977985
7.
Abeta associated neuropil changes: correlation with neuronal loss and dementia.
J Neuropathol Exp Neurol
; 57(12): 1122-30, 1998 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-9862634
8.
Abnormal alpha-synuclein interactions with Rab proteins in alpha-synuclein A30P transgenic mice.
J Neuropathol Exp Neurol
; 63(4): 302-13, 2004 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-15099020
9.
Nigral and cortical Lewy bodies and dystrophic nigral neurites in Parkinson's disease and cortical Lewy body disease contain alpha-synuclein immunoreactivity.
J Neuropathol Exp Neurol
; 57(4): 334-7, 1998 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-9600226
10.
Attenuation of delayed neuronal death after mild focal ischemia in mice by inhibition of the caspase family.
J Cereb Blood Flow Metab
; 18(3): 238-47, 1998 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-9498840
11.
Apolipoprotein E genotype and deposits of Abeta40 and Abeta42 in Alzheimer disease.
Arch Neurol
; 55(7): 1001-4, 1998 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-9678319
12.
Lack of association of a polymorphism in the low-density lipoprotein receptor-related protein gene with Alzheimer disease.
Arch Neurol
; 54(10): 1289-92, 1997 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-9341576
13.
Donepezil therapy in clinical practice: a randomized crossover study.
Arch Neurol
; 57(1): 94-9, 2000 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-10634454
14.
Apolipoprotein E genotype does not influence rates of cognitive decline in Alzheimer's disease.
Neurology
; 47(2): 444-8, 1996 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-8757018
15.
MRI measures of entorhinal cortex vs hippocampus in preclinical AD.
Neurology
; 58(8): 1188-96, 2002 Apr 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-11971085
16.
A newly identified polymorphism in the apolipoprotein E enhancer gene region is associated with Alzheimer's disease and strongly with the epsilon 4 allele.
Neurology
; 47(1): 196-201, 1996 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-8710077
17.
Clinicopathologic correlates in temporal cortex in dementia with Lewy bodies.
Neurology
; 53(9): 2003-9, 1999 Dec 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-10599772
18.
Nitric oxide in the cerebral cortex of amyloid-precursor protein (SW) Tg2576 transgenic mice.
Neuroscience
; 128(1): 73-89, 2004.
Artigo
em Inglês
| MEDLINE | ID: mdl-15450355
19.
Clinical and neuropathological correlates of dementia with Lewy bodies.
Ann N Y Acad Sci
; 920: 9-15, 2000.
Artigo
em Inglês
| MEDLINE | ID: mdl-11193181
20.
Clinical and neuropathological correlates of apolipoprotein E genotype in Alzheimer's disease. Window on molecular epidemiology.
Ann N Y Acad Sci
; 777: 158-65, 1996 Jan 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-8624079